The biology and management of non-small cell lung cancer
By R. Herbst, D. Morgensztern, C. Boshoff. Nature, 2018
4,141 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/ce2d16cb171060cbf8085eb88caa3864dd89b332
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
Citations in the corpus
- Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma (2020, background): “Despite therapeutic advances including tyrosine kinase inhibitors and immunotherapy, sustained responses are rare and prognosis remains poor (Herbst et al., 2018), with a 19% overall 5-year survival rate in the United States (Bray et al.”